BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
BlossomHill Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 18, 2026
$14.16+0.22 (+1.58%)
Close on Oct 19, 2026
- Market cap
- $38.43M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns BlossomHill Therapeutics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
7 buys · 0 sales
Net bought $25.18M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Chen Bihua | 3,615,362 | 11.80% | 13D (active) | Aug 6, 2026 |
| OrbiMed Capital GP VIII LLC | 2,714,279 | 8.90% | 13D (active) | Aug 10, 2026 |
| Perceptive Life Sciences Master Fund, Ltd. | 1,808,533 | 5.90% | 13G (passive) | Aug 7, 2026 |
| Vivo Innovation Fund II Holdings, L.P. | 1,681,240 | 5.50% | 13G (passive) | Aug 10, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jingrong Jean Cui | President and CEO, Director, 10% owner | 3,973,138 | 12.50% | Aug 10, 2026 |
| Yishan Li | Executive Chairman, Director, 10% owner | 3,859,703 | 12.14% | Aug 10, 2026 |
| Vincent Paul Liptak | General Counsel | 134,099 | 0.42% | Aug 10, 2026 |
| Jason A. Keyes | Chief Financial Officer | 700 | 0.00% | Aug 10, 2026 |
| Geoffrey Raymond Oxnard | Chief Medical Officer | 17,785 | 0.06% | Aug 10, 2026 |
| Advisors Llc Orbimed | Director | – | – | Aug 12, 2026 |
| Capital GP VIII LLC OrbiMed | Director | 2,714,279 | 8.54% | Aug 12, 2026 |
| Carl L. Gordon | Director | 2,714,279 | 8.54% | Aug 12, 2026 |
| John P. Schmid | Director | 6,000 | 0.02% | Aug 10, 2026 |
| Sundeep Agrawal | Director | 578,524 | 1.82% | Aug 10, 2026 |
| Bihua Chen | Director, 10% owner | – | – | Aug 10, 2026 |
| Sheila Gujrathi | Director | 90,160 | 0.28% | Aug 6, 2026 |
| Private Healthcare Fund III LP Cormorant | 10% owner | – | – | Aug 10, 2026 |
| Cormorant Asset Management, LP | 10% owner | – | – | Aug 10, 2026 |
| Cormorant Global Healthcare Master Fund, LP | 10% owner | – | – | Aug 10, 2026 |
| Private Healthcare Fund V. LP Cormorant | 10% owner | – | – | Aug 10, 2026 |
| Cormorant Private Healthcare Fund VI, LP | 10% owner | 3,301,534 | 10.39% | Aug 10, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Carl L. Gordon Director | Aug 10, 2026 | Buy | +625,000 | $16.00 | $10.00M | 2,714,279 |
| Carl L. Gordon Director | Aug 10, 2026 | Conversion | +1,039,996 | – | – | 1,039,996 |
| Carl L. Gordon Director | Aug 10, 2026 | Conversion | +1,049,283 | – | – | 2,089,279 |
| Capital GP VIII LLC OrbiMed Director | Aug 10, 2026 | Buy | +625,000 | $16.00 | $10.00M | 2,714,279 |
| Capital GP VIII LLC OrbiMed Director | Aug 10, 2026 | Conversion | +1,049,283 | – | – | 2,089,279 |
| Capital GP VIII LLC OrbiMed Director | Aug 10, 2026 | Conversion | +1,039,996 | – | – | 1,039,996 |
| John P. Schmid Director | Aug 10, 2026 | Buy | +6,000 | $16.00 | $96.00K | 6,000 |
| Yishan Li Executive Chairman, Director, 10% owner | Aug 10, 2026 | Conversion | +1,600,682 | – | – | 1,600,682 |
| Yishan Li Executive Chairman, Director, 10% owner | Aug 10, 2026 | Conversion | +124,779 | – | – | 124,779 |
| Yishan Li Executive Chairman, Director, 10% owner | Aug 10, 2026 | Conversion | +113,435 | – | – | 1,714,117 |
| Jason A. Keyes Chief Financial Officer | Aug 10, 2026 | Buy | +700 | $16.00 | $11.20K | 700 |
| Jingrong Jean Cui President and CEO, Director, 10% owner | Aug 10, 2026 | Conversion | +113,435 | – | – | 1,714,117 |
| Jingrong Jean Cui President and CEO, Director, 10% owner | Aug 10, 2026 | Conversion | +124,779 | – | – | 124,779 |
| Jingrong Jean Cui President and CEO, Director, 10% owner | Aug 10, 2026 | Conversion | +1,600,682 | – | – | 1,600,682 |
| Cormorant Private Healthcare Fund VI, LP 10% owner | Aug 10, 2026 | Conversion | +1,701,541 | – | – | 3,301,534 |
| Cormorant Private Healthcare Fund VI, LP 10% owner | Aug 10, 2026 | Conversion | +1,599,993 | – | – | 1,599,993 |
| Cormorant Private Healthcare Fund VI, LP 10% owner | Aug 10, 2026 | Buy | +312,500 | $16.00 | $5.00M | 3,614,034 |
| Sundeep Agrawal Director | Aug 10, 2026 | Conversion | +578,524 | – | – | 578,524 |
| Vincent Paul Liptak General Counsel | Aug 10, 2026 | Conversion | +22,687 | – | – | 22,687 |
| Vincent Paul Liptak General Counsel | Aug 10, 2026 | Buy | +2,200 | $16.00 | $35.20K | 111,412 |
| Vincent Paul Liptak General Counsel | Aug 7, 2026 | Buy | +2,500 | $15.80 | $39.50K | 109,212 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.